Introduction NO inhibition can influence blood pressure regulation and increase hypertension. Asymmetric dimethylarginine ADMA, is an analogue of L-arginine and its elevation inhibits NO synthesis, impairs endothelial function and is risk marker of cardiovascular diseases. In hypertension also reactive oxygen metabolites influence changes in signalisation and cell damages. In our study we focus on changes in ADMA level and oxidative stress in NO sythase inhibitors (L-NAME and 7-nitroindazole) treatment. Materials and Methods Spontaneously hypertensive rat (SHR) were chronically treated (up to 6 weeks) by L-NAME (50mg/kg) or 7NI (10mg/kg) and were comparing with control group. HPLC method withfluorescence detection has beenused to simultaneously analyse the levels of L-arginineand methylated stereoisomers: ADMA and SDMA. Plasma samples underwent solid-phase extraction followed by derivatization. Data acquisitions were achieved either using a classical standard method from calibration curve of an internal standard N-monomethyl-L-arginine- MMA (method 1) or using the method of several standard addition from linear regression extrapolation (method 2). Redox status has been determined by comparision of TTL vs. ROM level in plasma. Reactive oxygen metabolites – dROMsassay (Diacron, Grosseto, Italy) is a spectrophotometric method for determination of the hydroperoxides concetration reacting with a chromogenic substrate to develop a colored derivative. Total thiols levels -TTL assay (RelAssay, Gaziantep, Turkey) is based on the ability of free thiol groups to develop a colored complex when reacted with 5,5-dithiobis-2-nitrobenzoic acid (DTNB). The color intensity is directly related to the thiol groups which are not affected by oxidation. ROM and TTL plasma biomarkers were measured on a clinical autoanalyzerUnicelDxC 800 (Beckman-Coulter, Woerden, the Netherlands). Results and discussion Effects of the two potential exogenous NO-inhibitors: L-NAME and 7-NI, were compared. ADMA level, ROS and TTL have not been changed in the L-NAME group comparing to control SHR. Hovewer the administration of 7-NI markedly decreased the ADMA over-production in plasma (7NI 0,0630±0,012 µM vs Control 0,208± 0,033µM) and also increased and improve TTL/ROM redox level comparing to L-NAME group. It has been observed that 7-NI exogenous NO-inhibitor can correlated levels of ADMA, ROM and TTL in plasma of spontaneously hypertensive rats.
Read full abstract